Retrospective study of patients with histologically proven advanced melanoma treated with vemurafenib or ipilimumab
Latest Information Update: 06 Apr 2021
Price :
$35 *
At a glance
- Drugs Ipilimumab (Primary) ; Vemurafenib (Primary)
- Indications Malignant melanoma
- Focus Therapeutic Use
- 06 Apr 2021 New trial record